Cardiff Oncology shares plunge after Q2 earnings miss
Robert Kauffman, a director at Hagerty , Inc. (NYSE:HGTY), a $3.1 billion market cap company currently trading at $9.08, has recently sold a significant portion of his holdings in the company. According to InvestingPro data, the company maintains a "GOOD" financial health score. According to a filing with the SEC, Kauffman sold a total of 26,824 shares of Hagerty’s Class A Common Stock over three separate transactions. The sales, which took place on March 28, March 31, and April 1, 2025, were executed at prices ranging from $9.05 to $9.06 per share, amounting to a total transaction value of approximately $242,932. The company has shown strong revenue growth of nearly 20% over the last twelve months, though it currently trades at a relatively high P/E ratio of 91x.
These transactions were conducted under a Rule 10b5-1 trading plan, which Kauffman adopted on August 9, 2024. For investors seeking deeper insights, InvestingPro offers exclusive analysis and 7 additional ProTips for Hagerty, along with a comprehensive Pro Research Report. Following these sales, Kauffman, through Aldel LLC, retains ownership of 4,094,361 shares of Hagerty.
In other recent news, Hagerty Inc. reported its financial results for Q4 2024, exceeding earnings expectations with an EPS of $0.02, double the forecasted $0.01. The company’s revenue also surpassed estimates, reaching $292 million against a projected $279.53 million, marking a 19% increase year-over-year. Despite these positive financial results, Hagerty’s stock saw a decline in pre-market trading. The company has announced plans for significant investments in technology and market expansion as part of its strategic initiatives. Analysts from firms like Citizens JMP and Truist have shown interest in these developments, with inquiries about cross-selling strategies and the potential impacts of tariffs on operational costs. Hagerty’s CEO, Mikheel Hagerty, emphasized the company’s growth strategy, including the launch of new products and expansion into new markets. For 2025, Hagerty projects written premiums growth of 13-14% and total revenue growth of 12-13%, with expectations of net income to grow by 30-40%. The company is also investing in a technology transformation to support its long-term growth, which includes a transition to a modern cloud-based architecture.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.